DE3784835T2 - Chinoxalinon-derivate. - Google Patents

Chinoxalinon-derivate.

Info

Publication number
DE3784835T2
DE3784835T2 DE8787309160T DE3784835T DE3784835T2 DE 3784835 T2 DE3784835 T2 DE 3784835T2 DE 8787309160 T DE8787309160 T DE 8787309160T DE 3784835 T DE3784835 T DE 3784835T DE 3784835 T2 DE3784835 T2 DE 3784835T2
Authority
DE
Germany
Prior art keywords
quinoxalinone
dihydro
mol
ethyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787309160T
Other languages
German (de)
English (en)
Other versions
DE3784835D1 (de
Inventor
Reinhard Sarges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE3784835D1 publication Critical patent/DE3784835D1/de
Application granted granted Critical
Publication of DE3784835T2 publication Critical patent/DE3784835T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
DE8787309160T 1986-10-30 1987-10-16 Chinoxalinon-derivate. Expired - Fee Related DE3784835T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/002335 WO1992005160A1 (en) 1986-10-30 1986-10-30 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts

Publications (2)

Publication Number Publication Date
DE3784835D1 DE3784835D1 (de) 1993-04-22
DE3784835T2 true DE3784835T2 (de) 1993-06-24

Family

ID=22195697

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787309160T Expired - Fee Related DE3784835T2 (de) 1986-10-30 1987-10-16 Chinoxalinon-derivate.

Country Status (11)

Country Link
US (1) US4940708A (https=)
EP (1) EP0266102B1 (https=)
JP (1) JPS63295566A (https=)
AT (1) ATE86985T1 (https=)
DE (1) DE3784835T2 (https=)
DK (1) DK561487A (https=)
ES (1) ES2046206T3 (https=)
GR (1) GR3007402T3 (https=)
IE (1) IE68851B1 (https=)
PT (1) PT85998B (https=)
WO (1) WO1992005160A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940708A (en) * 1986-10-30 1990-07-10 Pfizer Inc. 4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, and salts
US6369057B1 (en) 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
PT509398E (pt) * 1991-04-15 2002-02-28 Aventis Pharma Gmbh Quinoxalinas processo para a sua preparacao e sua utilizacao
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
EP1940805A4 (en) * 2005-08-26 2009-11-11 Methylgene Inc BENZODIAZEPIN AND BENZOPIPERAZINANALOGA AS INHIBITORS OF HISTONDEACETYLASE
BRPI0911588B1 (pt) 2008-04-30 2018-07-17 Xyleco Inc método de preparo de um material de ração
US8236535B2 (en) 2008-04-30 2012-08-07 Xyleco, Inc. Processing biomass
US8212087B2 (en) 2008-04-30 2012-07-03 Xyleco, Inc. Processing biomass
US7867358B2 (en) 2008-04-30 2011-01-11 Xyleco, Inc. Paper products and methods and systems for manufacturing such products
KR101793398B1 (ko) 2008-10-28 2017-11-02 질레코 인코포레이티드 탄화수소-함유 재료의 처리방법
WO2022109292A1 (en) * 2020-11-20 2022-05-27 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and materials for inhibiting cb1 activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4209527A (en) * 1979-05-16 1980-06-24 Pfizer Inc. Benzimidazolone derivatives
US4940708A (en) * 1986-10-30 1990-07-10 Pfizer Inc. 4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, and salts

Also Published As

Publication number Publication date
PT85998A (en) 1987-11-01
IE872877L (en) 1988-04-28
EP0266102A2 (en) 1988-05-04
DE3784835D1 (de) 1993-04-22
EP0266102A3 (en) 1989-11-23
GR3007402T3 (https=) 1993-07-30
DK561487D0 (da) 1987-10-27
JPH0536436B2 (https=) 1993-05-31
DK561487A (da) 1988-08-08
IE68851B1 (en) 1996-07-24
JPS63295566A (ja) 1988-12-01
ES2046206T3 (es) 1994-02-01
WO1992005160A1 (en) 1992-04-02
PT85998B (pt) 1990-08-31
EP0266102B1 (en) 1993-03-17
US4940708A (en) 1990-07-10
ATE86985T1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
DE2933441C2 (de) Spiro-[4H-2,3-dihydrobenzopyran(4,5')oxazolidin]-2',4'-dione und solche Verbindungen enthaltende Arzneimittel
DE2228012C3 (de) Phthalidester der 6- [D(-)- a Aminophenylacetamido] -penicillansäure und Verfahren zu seiner Herstellung
DE3211676A1 (de) Neue derivate von cycloalka (c) pyrrol-carbonsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue cycloalka (c) pyrrol-carbonsaeuren als zwischenstufen und verfahren zu deren herstellung
DE69018876T2 (de) Pyridazinon-Derivate.
DE3784835T2 (de) Chinoxalinon-derivate.
DE2234651A1 (de) Eckige klammer auf 1-(p-chlorbenzoyl)5-methoxy-2-methyl-3-indol eckige klammer zu acetoxyessigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE2356903A1 (de) Verfahren zur herstellung substituierter chromon-3-carbonitrile, -carboxamide und -carbonsaeuren
DE3304019A1 (de) 3-acyloxy-1-phenyl-2-aminocarbonylindol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3813531A1 (de) Neue 2-aminoalkyl-4-benzyl-1-(2h)-phthalazinon-derivate
DE3141387C2 (https=)
EP0665228B1 (de) Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel
EP0008652B1 (de) Neue Zwischenprodukte und deren Verwendung zur Herstellung von neuen Oxadiazolopyrimidinderivaten
DE2424670A1 (de) Triazolo-isoindol-derivate und verfahren zu deren herstellung
DE69232812T2 (de) Neue cyclische aminophenylessigsäurederivate, ihre herstellung und immunomodulatoren , welche diese als aktiven bestandteil enthalten
DE69614553T2 (de) Aromatische carbonsaürediamide mit antigastrin wirkung, ihre herstellung und pharmazeutische verwendung
DE2748466A1 (de) 4a-aryloctahydro-1h-2-pyrindine
DE2427272C3 (de) 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
DE2923817C2 (de) (3-Alkylamino-2-hydroxyproposy)-furan-2-carbonsäureanilide und deren physiologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
EP0156091B1 (de) Beta-Oxo-alpha-carbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
DE3874465T2 (de) 1,2,3,4-tetrahydroisochonoline als antiarrhythmische mittel.
DE69227081T2 (de) Thiazolidin-2,4-dion-derivate, salze hiervon sowie verfahren zur herstellung
DE69612416T2 (de) Thiophenverbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE2217329A1 (de) Benzofuranderivate
EP0313935A2 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2804894A1 (de) Halogen-benzofuranon-carbonsaeuren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee